Ridgeback Biotherapeutics
(https://ridgebackbio.com) 📸 Data Snapshot: May 25, 2026
Trust & Proof — The Lens
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Trust & Proof
Verifiable evidence vs. Trust Theatre.
16
Impact Weight: 20 / 100
80% Reputation
Trust theatre is virtually non-existent despite minor schema errors. While the structured data identifies review_counts without dedicated review blocks, the actual content provides high-authority proof through citations to the New England Journal of Medicine, The Lancet, and the FDA. These are primary evidence sources, not secondary social proof theatre.
Proof density is significantly higher than the industry average. Across the analyzed pages, dozens of specific proof points exist, including regulatory clearance dates, supply agreements with UNICEF, and specific patent licensing via the Medicines Patent Pool.
Trust & Proof is read by weighing trust language against real verification. Below is the page-by-page tally of review mentions and external proof links, then the schema markup that may (or may not) declare verifiable ratings and identity proof.
🛡️ Trust Signals — reviews, proof links, trust-theatre check
25Review mentions (all pages)
0External proof links (all pages)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 3 | 0 |
| /cdn-cgi/l/email-protection/ | 0 | 0 |
| /press/ | 14 | 0 |
| /privacy-policy/ | 8 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: declared ratings, reviews & identity proof
Homepage schema
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://ridgebackbio.com/",
"url": "https://ridgebackbio.com/",
"name": "Ridgeback Biotherapeutics",
"isPartOf": {
"@id": "https://ridgebackbio.com/#website"
},
"about": {
"@id": "https://ridgebackbio.com/#organization"
},
"primaryImageOfPage": {
"@id": "https://ridgebackbio.com/#primaryimage"
},
"image": {
"@id": "https://ridgebackbio.com/#primaryimage"
},
"thumbnailUrl": "https://ridgebackbio.com/wp-content/uploads/2021/06/ridgeback-bio-staff-853x1024.jpg",
"datePublished": "2021-06-08T01:43:28+00:00",
"dateModified": "2022-03-21T19:58:38+00:00",
"description": "Ridgeback Biotherapeutics develops potential medications to treat infectious diseases like Ebola and COVID-19. Learn more.",
"breadcrumb": {
"@id": "https://ridgebackbio.com/#breadcrumb"
},
"inLanguage": "en-US",
"potentialAction": [
{
"@type": "ReadAction",
"target": [
"https://ridgebackbio.com/"
]
}
]
},
{
"@type": "ImageObject",
"inLanguage": "en-US",
"@id": "https://ridgebackbio.com/#primaryimage",
"url": "https://ridgebackbio.com/wp-content/uploads/2021/06/ridgeback-bio-staff.jpg",
"contentUrl": "https://ridgebackbio.com/wp-content/uploads/2021/06/ridgeback-bio-staff.jpg",
"width": 2400,
"height": 2880,
"caption": "Ridgeback Bio staff"
},
{
"@type": "BreadcrumbList",
"@id": "https://ridgebackbio.com/#breadcrumb",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home"
}
]
},
{
"@type": "WebSite",
"@id": "https://ridgebackbio.com/#website",
"url": "https://ridgebackbio.com/",
"name": "Ridgeback Biotherapeutics",
"description": "",
"publisher": {
"@id": "https://ridgebackbio.com/#organization"
},
"potentialAction": [
{
"@type": "SearchAction",
"target": {
"@type": "EntryPoint",
"urlTemplate": "https://ridgebackbio.com/?s={search_term_string}"
},
"query-input": {
"@type": "PropertyValueSpecification",
"valueRequired": true,
"valueName": "search_term_string"
}
}
],
"inLanguage": "en-US"
},
{
"@type": "Organization",
"@id": "https://ridgebackbio.com/#organization",
"name": "Ridgeback Biotherapeutics",
"url": "https://ridgebackbio.com/",
"logo": {
"@type": "ImageObject",
"inLanguage": "en-US",
"@id": "https://ridgebackbio.com/#/schema/logo/image/",
"url": "https://ridgebackbio.com/wp-content/uploads/2022/04/logo.svg",
"contentUrl": "https://ridgebackbio.com/wp-content/uploads/2022/04/logo.svg",
"width": 243,
"height": 60,
"caption": "Ridgeback Biotherapeutics"
},
"image": {
"@id": "https://ridgebackbio.com/#/schema/logo/image/"
},
"sameAs": [
"https://www.crunchbase.com/organization/ridgeback-biotherapeutics",
"https://www.linkedin.com/company/ridgeback-biotherapeutics",
"https://www.bloomberg.com/profile/company/1746558D:US"
],
"mainEntityOfPage": [
"https://www.cnbc.com/video/2021/10/01/ridgeback-biotherapeutics-co-founders-on-potential-covid-pill-supply.html",
"https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat/",
"https://www.biopharminternational.com/view/merck-and-ridgeback-biotherapeutics-oral-antiviral-covid-19-treatment-reduces-risk-of-hospitalization-or-death-by-50-",
"https://www.cnn.com/2021/11/04/health/uk-authorizes-merck-antiviral-molnupiravir-covid/index.html",
"https://www.prnewswire.com/news-releases/ridgeback-biotherapeutics-and-drug-innovations-ventures-at-emory-partner-to-develop-clinical-stage-coronavirus-treatment-301027190.html",
"https://www.fiercepharma.com/keyword/ridgeback-biotherapeutics"
],
"description": "Ridgeback Biotherapeutics develops potential medications to treat infectious diseases that have limited or no treatment options, like Ebola and COVID-19.",
"address": {
"@type": "PostalAddress",
"streetAddress": "3480 Main Highway",
"addressLocality": "Miami",
"addressRegion": "FL",
"postalCode": "33133",
"addressCountry": "United States",
"telephone": "1 786 687 2495"
}
}
]
}
/cdn-cgi/l/email-protection/ — no schema detected (entity gap)
/press/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "CollectionPage",
"@id": "https://ridgebackbio.com/press/",
"url": "https://ridgebackbio.com/press/",
"name": "Press Coverage for Ridgeback Biotherapeutics",
"isPartOf": {
"@id": "https://ridgebackbio.com/#website"
},
"description": "Read recent media articles, press releases, and presentations for EBANGA and molupiravir.",
"breadcrumb": {
"@id": "https://ridgebackbio.com/press/#breadcrumb"
},
"inLanguage": "en-US"
},
{
"@type": "BreadcrumbList",
"@id": "https://ridgebackbio.com/press/#breadcrumb",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://ridgebackbio.com/"
},
{
"@type": "ListItem",
"position": 2,
"name": "Press"
}
]
},
{
"@type": "WebSite",
"@id": "https://ridgebackbio.com/#website",
"url": "https://ridgebackbio.com/",
"name": "Ridgeback Biotherapeutics",
"description": "",
"publisher": {
"@id": "https://ridgebackbio.com/#organization"
},
"potentialAction": [
{
"@type": "SearchAction",
"target": {
"@type": "EntryPoint",
"urlTemplate": "https://ridgebackbio.com/?s={search_term_string}"
},
"query-input": {
"@type": "PropertyValueSpecification",
"valueRequired": true,
"valueName": "search_term_string"
}
}
],
"inLanguage": "en-US"
},
{
"@type": "Organization",
"@id": "https://ridgebackbio.com/#organization",
"name": "Ridgeback Biotherapeutics",
"url": "https://ridgebackbio.com/",
"logo": {
"@type": "ImageObject",
"inLanguage": "en-US",
"@id": "https://ridgebackbio.com/#/schema/logo/image/",
"url": "https://ridgebackbio.com/wp-content/uploads/2022/04/logo.svg",
"contentUrl": "https://ridgebackbio.com/wp-content/uploads/2022/04/logo.svg",
"width": 243,
"height": 60,
"caption": "Ridgeback Biotherapeutics"
},
"image": {
"@id": "https://ridgebackbio.com/#/schema/logo/image/"
},
"sameAs": [
"https://www.crunchbase.com/organization/ridgeback-biotherapeutics",
"https://www.linkedin.com/company/ridgeback-biotherapeutics",
"https://www.bloomberg.com/profile/company/1746558D:US"
],
"mainEntityOfPage": [
"https://www.cnbc.com/video/2021/10/01/ridgeback-biotherapeutics-co-founders-on-potential-covid-pill-supply.html",
"https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat/",
"https://www.biopharminternational.com/view/merck-and-ridgeback-biotherapeutics-oral-antiviral-covid-19-treatment-reduces-risk-of-hospitalization-or-death-by-50-",
"https://www.cnn.com/2021/11/04/health/uk-authorizes-merck-antiviral-molnupiravir-covid/index.html",
"https://www.prnewswire.com/news-releases/ridgeback-biotherapeutics-and-drug-innovations-ventures-at-emory-partner-to-develop-clinical-stage-coronavirus-treatment-301027190.html",
"https://www.fiercepharma.com/keyword/ridgeback-biotherapeutics"
],
"description": "Ridgeback Biotherapeutics develops potential medications to treat infectious diseases that have limited or no treatment options, like Ebola and COVID-19.",
"address": {
"@type": "PostalAddress",
"streetAddress": "3480 Main Highway",
"addressLocality": "Miami",
"addressRegion": "FL",
"postalCode": "33133",
"addressCountry": "United States",
"telephone": "1 786 687 2495"
}
}
]
}
/privacy-policy/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://ridgebackbio.com/privacy-policy/",
"url": "https://ridgebackbio.com/privacy-policy/",
"name": "Privacy Policy and Terms of Use - Ridgeback Biotherapeutics",
"isPartOf": {
"@id": "https://ridgebackbio.com/#website"
},
"datePublished": "2021-06-04T03:52:55+00:00",
"dateModified": "2021-06-23T20:39:21+00:00",
"description": "Our policies and procedures on the collection, use and disclosure of Your information when You use the Service. Learn more.",
"breadcrumb": {
"@id": "https://ridgebackbio.com/privacy-policy/#breadcrumb"
},
"inLanguage": "en-US",
"potentialAction": [
{
"@type": "ReadAction",
"target": [
"https://ridgebackbio.com/privacy-policy/"
]
}
]
},
{
"@type": "BreadcrumbList",
"@id": "https://ridgebackbio.com/privacy-policy/#breadcrumb",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://ridgebackbio.com/"
},
{
"@type": "ListItem",
"position": 2,
"name": "Privacy Policy and Terms of Use"
}
]
},
{
"@type": "WebSite",
"@id": "https://ridgebackbio.com/#website",
"url": "https://ridgebackbio.com/",
"name": "Ridgeback Biotherapeutics",
"description": "",
"publisher": {
"@id": "https://ridgebackbio.com/#organization"
},
"potentialAction": [
{
"@type": "SearchAction",
"target": {
"@type": "EntryPoint",
"urlTemplate": "https://ridgebackbio.com/?s={search_term_string}"
},
"query-input": {
"@type": "PropertyValueSpecification",
"valueRequired": true,
"valueName": "search_term_string"
}
}
],
"inLanguage": "en-US"
},
{
"@type": "Organization",
"@id": "https://ridgebackbio.com/#organization",
"name": "Ridgeback Biotherapeutics",
"url": "https://ridgebackbio.com/",
"logo": {
"@type": "ImageObject",
"inLanguage": "en-US",
"@id": "https://ridgebackbio.com/#/schema/logo/image/",
"url": "https://ridgebackbio.com/wp-content/uploads/2022/04/logo.svg",
"contentUrl": "https://ridgebackbio.com/wp-content/uploads/2022/04/logo.svg",
"width": 243,
"height": 60,
"caption": "Ridgeback Biotherapeutics"
},
"image": {
"@id": "https://ridgebackbio.com/#/schema/logo/image/"
},
"sameAs": [
"https://www.crunchbase.com/organization/ridgeback-biotherapeutics",
"https://www.linkedin.com/company/ridgeback-biotherapeutics",
"https://www.bloomberg.com/profile/company/1746558D:US"
],
"mainEntityOfPage": [
"https://www.cnbc.com/video/2021/10/01/ridgeback-biotherapeutics-co-founders-on-potential-covid-pill-supply.html",
"https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat/",
"https://www.biopharminternational.com/view/merck-and-ridgeback-biotherapeutics-oral-antiviral-covid-19-treatment-reduces-risk-of-hospitalization-or-death-by-50-",
"https://www.cnn.com/2021/11/04/health/uk-authorizes-merck-antiviral-molnupiravir-covid/index.html",
"https://www.prnewswire.com/news-releases/ridgeback-biotherapeutics-and-drug-innovations-ventures-at-emory-partner-to-develop-clinical-stage-coronavirus-treatment-301027190.html",
"https://www.fiercepharma.com/keyword/ridgeback-biotherapeutics"
],
"description": "Ridgeback Biotherapeutics develops potential medications to treat infectious diseases that have limited or no treatment options, like Ebola and COVID-19.",
"address": {
"@type": "PostalAddress",
"streetAddress": "3480 Main Highway",
"addressLocality": "Miami",
"addressRegion": "FL",
"postalCode": "33133",
"addressCountry": "United States",
"telephone": "1 786 687 2495"
}
}
]
}
Explore the other reputation pillars for Ridgeback Biotherapeutics
Analysis Disclosure & Source Attribution
This page presents a snapshot of public data from Ridgeback Biotherapeutics, captured on May 25, 2026, to show how machine logic reads Trust & Proof signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to Ridgeback Biotherapeutics: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://ridgebackbio.com to view the most current version of its content and see directly what this company is about and what it offers.